Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CD3 epsilon anticorps

Cet anticorps Human Monoclonal détecte spécifiquement CD3 epsilon dans FACS. Il présente une réactivité envers Souris.
N° du produit ABIN7795319

Aperçu rapide pour Recombinant CD3 epsilon anticorps (ABIN7795319)

Antigène

Voir toutes CD3 epsilon (CD3E) Anticorps
CD3 epsilon (CD3E)

Type d'anticorp

Recombinant Antibody

Reactivité

  • 352
  • 206
  • 51
  • 43
  • 21
  • 19
  • 8
  • 8
  • 8
  • 7
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Souris

Hôte

  • 210
  • 175
  • 47
  • 38
  • 23
  • 12
  • 6
  • 2
  • 2
  • 1
  • 1
Human

Clonalité

  • 394
  • 115
  • 7
Monoclonal

Conjugué

  • 180
  • 39
  • 35
  • 24
  • 23
  • 12
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 8
  • 8
  • 8
  • 8
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD3 epsilon est non-conjugé

Application

  • 367
  • 217
  • 182
  • 133
  • 118
  • 88
  • 48
  • 33
  • 32
  • 27
  • 27
  • 22
  • 21
  • 14
  • 13
  • 8
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

145-2C11
  • Expression System

    Mammalian cells

    Fonction

    Recombinant Anti-mouse CD3e Monoclonal Antibody (Clone: 145-2C11), Human IgG1 Fc Silent Kappa

    Attributs du produit

    The antibody binds to CD3 epsilon of the T cell receptor-CD3 complex found only on mature T cells and medullary thymocytes. An interaction between T cells, the antibody, and monocytes causes T-cell activation (mitogenesis) in vitro. On the other hand, the antibody blocks the unique association between the antigen receptor and CD3, and both the generation and function of cytotoxic T cells. After an initial dose of the antibody, T cells disappear from the circulation within minutes to hours. During treatment with the antibody, T cells bearing the usual array of surface molecules (CD2, CD4, and CD8) reappear in the peripheral blood circulation but these cells are devoid of CD3. After another 48 hours without the antibody, the normal array of surface molecules including CD3 appear again on all T cells. The selective removal of CD3 by internalization is thought to be the key mechanism of action of the antibody. Comodulation of the antigen receptor with CD3 explains the immunoblocking action of the antibody in vivo. The antibody is ineffective clinically if the CD3 target molecule is not modulated. The antibody is effective for induction of immunosuppression and for treating initial and steroid-resistant rejections.

    Purification

    Protein A or G affinity column

    Pureté

    >95 % by reducing SDS-PAGE

    Isotype

    Fc Silenced, IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    > 3 mg/mL

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Antigène

    CD3 epsilon (CD3E)

    Autre désignation

    CD3e

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Ubiquitin Proteasome Pathway
Vous êtes ici:
Chat with us!